Paired to the launch of the Lancet NCDI Poverty Commission report in September 2020, this policy brief provides a high level overview of the findings and recommendations from the Commission report, as part of efforts to address one of the most glaring inequities in global health.
Released by The Lancet Commission on Reframing NCDs and Injuries for the Poorest Billion (The Lancet NCDI Poverty Commission) in September 2020, this landmark report highlights key findings and recommendations demonstrating the magnitude and pattern of the NCDI burden in several low and low-middle income countries (LLMICs) in Sub-Saharan Africa, the Caribbean, and South Asia as well as emphasizing the disparities existing in care and resources available for NCDs and injuries.
This commentary discusses of the impact of COVID-19 on type 1 diabetes (T1D) care in low-middle income countries (LMICs), due to the exacerbations of COVID on access to insulin, blood glucose monitoring, and availability of expert clinical care. Through various country examples, the authors describes these challenges and their evolving responses.
These guidelines, created by Santé Diabète, outline the risks of COVID-19 for noncommunicable disease patients, feature case studies in Mali, Burkina Faso and Comoros, and details the strategic response for COVID-19 implemented by Santé Diabète.
Created by the NCD Synergies team, the attached resource document outlines clinical considerations for patients with chronic disease through the COVID-19 crisis.
NCD Synergies
HEALTH EQUITY FOR THE POOREST BILLION
